Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
CellsBin is a VC-backed startup that offers drug discovery, immunotherapy, and toxicity testing.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat diseases.
Intus Bio develops biotechnology solutions centered on microbiome analysis and diagnostic discovery.
MALCOVA is a medical device startup delivering novel hardware and AI-based software solutions to resolve needs in the radiology market.
AiM Medical Robotics is a biotechnology company developing a robotic system for use in neurosurgical procedures.
QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
mPath Health is a cloud-based automation software platform that helps to improve preventive care.
Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.
Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical Device, Pharmaceutical. The firm invests across 25 different industry categories.
Among tracked funding rounds, ZetaGen Therapeutics received $12.9M in a Series B round. National Cancer Institute's total known invested capital is $325.9M.
National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.
Recent National Cancer Institute portfolio additions include CellsBin, Xylyx Bio, Senticell, Intus Bio, MALCOVA. These companies were founded in 2020 or later.